1.Enhanced neutrophil functions by recombinant human granulocyte colony-stimulating factor in diabetic patients with foot infections in vitro.
Kyong Ran PECK ; Dong Woo SON ; Jae Hoon SONG ; Sungmin KIM ; Myoung Don OH ; Kang Won CHOE
Journal of Korean Medical Science 2001;16(1):39-44
This study was performed to evaluate the effect of granulocyte-colony stimulating factor on neutrophil functions in diabetic patients with active foot infections in vitro. Twelve diabetic patients with foot infections and 12 normal volunteers were enrolled. Neutrophils from peripheral blood were incubated with granulocyte colony-stimulating factor (G-CSF, 50 ng/mL) for 20 min. Superoxide production of neutrophils was measured by the reduction of ferricytochrome C. Neutrophil phagocytosis was assayed using Staphylococcus aureus and the weighted phagocytic index was calculated. Superoxide production of neutrophils in diabetic patients with foot infections was 7.7 (unit: nmol/2 x 10(5) cells/60 min), which was significantly lower than that in controls (12.0) (p<0.05). G-CSF increased neutrophil superoxide production to 12.1 in diabetic patients with foot infections and to 19.8 in controls (p<0.05 for each). Weighted phagocytic index in diabetic patients with foot infections was 0.77, which was not significantly different from that of the controls (0.69). Weighted phagocytic index was increased significantly by G-CSF to 0.88 in diabetic patients with foot infections and to 0.79 in controls (p<0.05 for each). In conclusion, G-CSF significantly enhanced neutrophil functions in diabetic patients with foot infections in vitro.
Adult
;
Aged
;
Bacterial Infections/immunology*
;
Diabetes Mellitus/immunology*
;
Female
;
Foot Diseases/immunology*
;
Granulocyte Colony Stimulating Factor, Recombinant/pharmacology*
;
Human
;
Male
;
Middle Age
;
Neutrophils/immunology
;
Neutrophils/drug effects*
;
Receptors, IgG/analysis
;
Superoxides/metabolism
2.Association of the time that elapsed from last vaccination with protective effectiveness against foot-and-mouth disease in small ruminants.
Ehud ELNEKAVE ; Boris EVEN-TOV ; Boris GELMAN ; Beni SHARIR ; Eyal KLEMENT
Journal of Veterinary Science 2015;16(1):87-92
Routine and emergency vaccination of small ruminants against foot-and-mouth disease (FMD) is mandatory in many endemic countries, yet data on the field effectiveness of the vaccines used is scarce. We conducted an investigation of a serotype O FMD outbreak that took place in a sheep and goat pen, and estimated the effectiveness of various routine vaccination statuses. We also evaluated the protection provided by colostrum administration and emergency vaccination. Animals which were routinely vaccinated twice were not clinically affected while disease incidence was observed among animals routinely vaccinated only once (p = 0.004 according to a two-sided Fisher's exact test). In groups vaccinated only once, there was a significant association between the average time that elapsed since last vaccination and the disease incidence (n = 5; Spearman correlation coefficient: r(s) = 1.0, p < 0.01). In addition, non-vaccinated lambs fed colostrum from dams vaccinated more than 2 months before parturition had a mortality rate of 33%. Administration of emergency vaccination 2 days after the occurrence of the index case was the probable reason for the rapid blocking of the FMD spread within 6 days from its onset in the pen.
Animals
;
Colostrum
;
Disease Outbreaks/veterinary
;
Foot-and-Mouth Disease/*prevention & control
;
Goat Diseases/*prevention & control
;
Goats
;
Immunization Schedule
;
Sheep
;
Sheep Diseases/*prevention & control
;
Viral Vaccines/administration & dosage/*immunology
3.Expression and utilization of 3AB nonstructural protein of foot-and-mouth disease virus in Escherichia coli.
Junjun SHAO ; Huiyun CHANG ; Tong LIN ; Guozheng CONG ; Junzheng DU ; Shandian GAO
Chinese Journal of Biotechnology 2011;27(2):180-184
To develop a sensitive and specific ELISA for detection of antibodies to the nonstructural protein of FMDV. We cloned and expressed FMDV nonstructural protein 3AB in Escherichia coli expression system. The recombinant protein 3AB was purified with Ni-NTA HisBind Resins and characterized by Western blotting. An indirect ELISA based on purified protein 3AB as a coating antigen was established. The specificity and sensitivity of this assay were evaluated by comparison with a commercial 3ABC-ELISA kit in detecion of serum samples. The results showed that the recombinant protein 3AB was expressed as a formation of inclusion bodies in Escherichia coli. The purified protein could specificially react with FMDV infection antibodies in Western blotting assay, but no reaction with the immune antibodies induced with vaccine. Two assays were no significant differences in specificity and sensitivity for detection of field samples (P>0.05). Therefore, we speculated that the recombinant protein 3AB is a promising molecular marker, which may effectively differentiate FMD-infected from vaccinated animals in a herd.
Animals
;
Antibodies, Viral
;
analysis
;
Antigens, Viral
;
biosynthesis
;
genetics
;
immunology
;
Cattle
;
Cattle Diseases
;
diagnosis
;
immunology
;
Enzyme-Linked Immunosorbent Assay
;
Escherichia coli
;
genetics
;
metabolism
;
Foot-and-Mouth Disease
;
diagnosis
;
immunology
;
Foot-and-Mouth Disease Virus
;
chemistry
;
genetics
;
isolation & purification
;
Genetic Vectors
;
genetics
;
Recombinant Proteins
;
biosynthesis
;
genetics
;
immunology
;
Viral Nonstructural Proteins
;
biosynthesis
;
genetics
;
immunology
4.Dietary germanium biotite supplementation enhances the induction of antibody responses to foot-and-mouth disease virus vaccine in pigs.
Jin A LEE ; Bock Gie JUNG ; Myunghwan JUNG ; Tae Hoon KIM ; Han Sang YOO ; Bong Joo LEE
Journal of Veterinary Science 2014;15(3):443-447
We evaluated the potential ability of germanium biotite (GB) to stimulate the production of antibodies specific for foot-and-mouth disease virus (FMDV). To this aim, we measured the total FMDV-specific antibody responses and IgM production after vaccination against FMD both experimentally and in the field. GB supplementation with FMDV vaccination stimulated the production of anti-FMDV antibodies, and effectively increased IFN-gamma and TNF-alpha levels. These results suggest that GB may be a novel alternative feed supplement that can serve as a boosting agent and an immunostimulator for increasing the efficacy of FMDV vaccination in pigs.
Adjuvants, Immunologic/therapeutic use
;
Aluminum Silicates/*therapeutic use
;
Animals
;
Antibodies, Viral/*immunology
;
Antibody Formation/drug effects
;
*Dietary Supplements
;
Ferrous Compounds/*therapeutic use
;
Foot-and-Mouth Disease/*immunology/prevention & control
;
Foot-and-Mouth Disease Virus/immunology
;
Germanium/*therapeutic use
;
Swine
;
Swine Diseases/immunology/prevention & control/*virology
5.Identification and antigenic site analysis of foot-and-mouth disease virus from pigs and cattle in Korea.
Jae Ku OEM ; Kwang Nyeong LEE ; In Soo CHO ; Soo Jeong KYE ; Jee Yong PARK ; Jong Hyeon PARK ; Yong Joo KIM ; Yi Seok JOO ; Hee Jong SONG
Journal of Veterinary Science 2005;6(2):117-124
From May to June 2002, a total of 16 foot-and mouth disease (FMD) outbreaks due to the serotype O virus, Pan Asia strain, were recorded in Korea. The viruses were identified by antigen ELISA, RT-PCR and sequence analysis. The overall nucleotide sequence divergence of the VP1 region among the 4 isolates in 2002 was 0 to 1.4%, but between O/SKR/2002 and O/SKR/2000 isolates was 1.9-4.9%. Phylogenetic analysis with the some known strains from East Asian countries showed that the 4 Korean isolates in 2002 formed one distinct cluster, which different from clusters of Korean isolates in 2000, with in the same lineage of the ME-SA topotype strains. Deduced amino acid sequences around neutralizable antigenic site on VP1 site of O/SKR/2002 isolates were aligned and compared with other strains. At the antigenic site 1, the replacements of the critical amino acid residues at position 144 from V to L and at position 152 from A to T were observed in O/SKR/2002 viruses. For antigenic site 2 and 4, there were not significant variations in general. At the antigenic site 3, the substitutions of amino acid residues were present at positions 54 and 56 in O/SKR/2002 isolates and an alternative residue I at position 54 are observed only at the sequence of O/SKR/AS/2002 (cow) virus. And the substitution (L-->P) of significant residue at position 144 was detected at the amino acid sequence of the O/SKR/2002 (cow) virus.
Amino Acid Sequence
;
Animals
;
Antibodies, Viral/blood
;
Base Sequence
;
Capsid Proteins/genetics/*immunology
;
Cattle
;
Cattle Diseases/epidemiology/*virology
;
Cluster Analysis
;
Disease Outbreaks/*veterinary
;
Enzyme-Linked Immunosorbent Assay/veterinary
;
Epitopes/analysis
;
Foot-and-Mouth Disease/epidemiology/*virology
;
Foot-and-Mouth Disease Virus/genetics/*immunology
;
Korea/epidemiology
;
Molecular Sequence Data
;
Phylogeny
;
RNA, Viral/chemistry/genetics
;
Reverse Transcriptase Polymerase Chain Reaction/veterinary
;
Sequence Alignment
;
Swine
;
Swine Diseases/epidemiology/*virology